Consolidated Statement Of Cash Flows

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7541066

Concept As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
3,813,821,000 JPY
5,889,883,000 JPY
Depreciation
830,652,000 JPY
741,012,000 JPY
Impairment losses
3,165,000 JPY
620,000 JPY
Amortization of goodwill
37,370,000 JPY
18,685,000 JPY
Increase (decrease) in allowance for doubtful accounts
-8,307,000 JPY
-142,000 JPY
Interest and dividend income
-86,914,000 JPY
-17,004,000 JPY
Interest expenses
62,692,000 JPY
61,181,000 JPY
Foreign exchange losses (gains)
-444,312,000 JPY
-2,562,262,000 JPY
Share of loss (profit) of entities accounted for using equity method
-1,239,850,000 JPY
-1,113,023,000 JPY
Decrease (increase) in trade receivables
-369,925,000 JPY
329,251,000 JPY
Subtotal
380,408,000 JPY
2,970,633,000 JPY
Income taxes paid
-726,041,000 JPY
-725,203,000 JPY
Decrease (increase) in inventories
-2,637,341,000 JPY
-890,227,000 JPY
Increase (decrease) in trade payables
-163,020,000 JPY
-518,160,000 JPY
Net cash provided by (used in) operating activities
687,931,000 JPY
2,792,106,000 JPY
Other, net
-1,173,918,000 JPY
996,391,000 JPY
Interest and dividends received
1,092,278,000 JPY
610,291,000 JPY
Loss (gain) on sale of non-current assets
-1,073,000 JPY
-675,000 JPY
Interest paid
-58,714,000 JPY
-63,614,000 JPY
Cash flows from investing activities
Proceeds from withdrawal of time deposits
JPY
2,448,200,000 JPY
Purchase of property, plant and equipment
-2,931,345,000 JPY
-1,842,168,000 JPY
Proceeds from sale of property, plant and equipment
4,619,000 JPY
675,000 JPY
Net cash provided by (used in) investing activities
-3,671,934,000 JPY
-2,579,651,000 JPY
Purchase of investment securities
-139,979,000 JPY
-1,157,494,000 JPY
Proceeds from sale of investment securities
274,988,000 JPY
JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-850,364,000 JPY
-1,937,239,000 JPY
Other, net
-9,882,000 JPY
-51,338,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-284,000 JPY
Proceeds from long-term borrowings
9,000,000,000 JPY
10,150,000,000 JPY
Dividends paid
-1,243,832,000 JPY
-1,655,637,000 JPY
Dividends paid to non-controlling interests
-2,950,000 JPY
JPY
Repayments of long-term borrowings
-2,689,035,000 JPY
-1,717,844,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-15,457,000 JPY
JPY
Net cash provided by (used in) financing activities
2,124,234,000 JPY
6,270,035,000 JPY
Effect of exchange rate change on cash and cash equivalents
887,759,000 JPY
769,055,000 JPY
Net increase (decrease) in cash and cash equivalents
27,990,000 JPY
7,251,545,000 JPY
Cash and cash equivalents
9,225,685,000 JPY
9,197,694,000 JPY
11,798,102,000 JPY
4,548,792,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.